Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01466114
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:31.338179+00:00
Published At
2019-11-06T00:00:00+00:00
Record Updated At
2019-11-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Relapsing-remitting Multiple Sclerosis", "Secondary-progressive Multiple Sclerosis", "Primary-progressive Multiple Sclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-11-06"
protocolSection.identificationModule.nctId
"NCT01466114"
protocolSection.identificationModule.officialTitle
"A Double-Blind, Placebo Controlled Trial of Estriol Treatment in Women With Multiple Sclerosis: Effect on Cognition."
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Relapsing-remitting Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Secondary-progressive Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Primary-progressive Multiple Sclerosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.